Semaglutide
STEP 5
Novo Nordisk · Phase 3 · Completed · Enrollment 304
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide | Obesity or overweight | n/r | 4 | Efficacy | n/r |
| Placebo | Obesity or overweight | n/r | 4 | Efficacy | n/r |
| Semaglutide 2.4 mg, in trial | Obesity or overweight | 2.4 mg | n/r | ITT | n/r |
| Placebo, in trial | Obesity or overweight | n/r | n/r | ITT | n/r |